Faculty Disclosures
| Kevin M. Flanigan, MD, FAAN |
Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Armatus. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne. The institution of Dr. Flanigan has received research support from Ultragenyx . The institution of Dr. Flanigan has received research support from Solid Biosciences. The institution of Dr. Flanigan has received research support from Dyne Therapeutics. The institution of Dr. Flanigan has received research support from Avidity. |
| Catherine Parisien |
Ms. Parisien has nothing to disclose. |
| Kristen Truxal, MD |
The institution of Dr. Truxal has received research support from Ultragenyx. The institution of Dr. Truxal has received research support from Inozyme Therapeutics. |
| Samuel J. Goodchild, PhD |
Dr. Goodchild has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Goodchild has stock in Xenon Pharmaceuticals. |
| Wildon Farwell, MD |
Dr. Farwell has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Farwell has received personal compensation for serving as an employee of Satellos Biosciences. Dr. Farwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Paragon Therapeutics. Dr. Farwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Farwell has stock in Dyne Therapeutics. Dr. Farwell has stock in Satellos Bioscience. |
| Nancy L. Kuntz, MD, FAAN |
Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Affinia Therapeutics. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. |
| Mariam A. Mostafa II, MBBS |
Dr. Mostafa has nothing to disclose. |
| Stephen Kingsmore |
Stephen Kingsmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Third Rock Ventures. Stephen Kingsmore has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB2 Bio. Stephen Kingsmore has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Illumina. Stephen Kingsmore has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACMGG. Stephen Kingsmore has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Stephen Kingsmore has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Rady Children's Institute for Genomic Medicine. Stephen Kingsmore has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Sidra Medicine. Stephen Kingsmore has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Stephen Kingsmore has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cold Spring Harbor Press. Stephen Kingsmore has stock in Third Rock Ventures. The institution of Stephen Kingsmore has received research support from Alexion, Amgen, Biomarin, Chiesi, Inozyme, Ionis, Mahzi, Orchard, Sanofi, Rocket, Sarepta, Sentynyl, Travere, Ultragenyx. The institution of Stephen Kingsmore has received research support from NIH. Stephen Kingsmore has received intellectual property interests from a discovery or technology relating to health care. Stephen Kingsmore has received intellectual property interests from a discovery or technology relating to health care. |
| Pam Ventola, PhD |
Dr. Ventola has received personal compensation for serving as an employee of Cogstate. The institution of Dr. Ventola has received research support from NIH. |
| Stefania Corti, MD, PhD |
Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. |
| Maja Filipovic, BSc |
Ms. Filipovic has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Ms. Filipovic has stock in Xenon Pharmaceuticals. |
| samrat thouta, PhD |
Dr. thouta has received personal compensation for serving as an employee of Xenon Pharamceuticals. Dr. thouta has stock in Xenon Pharmaceuticals. |
| Eines Monteagudo, MD |
Mrs. Monteagudo has nothing to disclose. |
| Anna Kostera-Pruszczyk |
Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneka. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. |
| Amatul Aala, MBBS |
Miss Aala has nothing to disclose. |
| Simona Lodato |
Simona Lodato has nothing to disclose. |
| Mireia del Toro, MD |
Dr. del Toro has nothing to disclose. |
| Yehia Nabil |
Yehia Nabil has nothing to disclose. |
| Sarah Glass, PhD |
Dr. Glass has received personal compensation for serving as an employee of n-Lorem Foundation . |
| Joseph G. Gleeson, MD |
Prof. Gleeson has received personal compensation for serving as an employee of Ionis. Prof. Gleeson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. |
| Aima Muzaffar, MBBS |
Dr. Muzaffar has nothing to disclose. |
| Ryan Mitchell, PhD |
Dr. Mitchell has received personal compensation for serving as an employee of Satellos Bioscience. |
| Andreas Brunklaus, MD |
Prof. Brunklaus has received personal compensation in the range of $0-$499 for serving as a Consultant for Servier. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded Therapeutics. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biocodex. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. |
| Linda Laux, MD |
Dr. Laux has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Laux has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. |
| Jessie Lynch |
Mrs. Lynch has received personal compensation for serving as an employee of Stoke Therapeutics. Mrs. Lynch has stock in Stoke Therapeutics. |
| Chiara Cordiglieri, PhD |
Dr. Cordiglieri has nothing to disclose. |
| He Pu, PhD |
Dr. Pu has received personal compensation for serving as an employee of n-Lorem Foundation. |
| Harrison Clement, MS |
Mr. Clement has nothing to disclose. |
| Ubaid Ur Rehman, MBBS |
Dr. Rehman has nothing to disclose. |
| Nourhan Hatem II, MD |
Dr. Hatem has nothing to disclose. |
| Brian Werneburg |
Mr. Werneburg has received personal compensation for serving as an employee of Stoke Therapeutics. |
| Francesca Beatrice |
Francesca Beatrice has nothing to disclose. |
| Emily Hurley |
Ms. Hurley has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. |
| Lan Lan, MD |
Mrs. Lan has received personal compensation for serving as an employee of argenx. |
| Juliette Giacobbe, PhD |
Dr. Giacobbe has received personal compensation for serving as an employee of argenx. Dr. Giacobbe has stock in argenx. |
| María Jose Lopez, MD, PhD |
Dr. Lopez has nothing to disclose. |
| Laurence Mignon, PhD |
Dr. Mignon has received personal compensation for serving as an employee of n-Lorem Foundation. Dr. Mignon has stock in Ionis Pharmaceuticals, JNJ, Nvidia.. The institution of Dr. Mignon has received research support from CIRM. |
| M. S. Perry, MD |
Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stoke therapeutics. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for jazz pharmaceuticals. Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for azurity. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Dr. Perry has stock in Praxis Precision Medicine. Dr. Perry has stock in Biohaven. Dr. Perry has stock in Rapport. Dr. Perry has stock in Alto Neurosciences. Dr. Perry has a non-compensated relationship as a president with child neurology foundation that is relevant to AAN interests or activities. Dr. Perry has a non-compensated relationship as a President with Pediatric Epilepsy Research Consortium that is relevant to AAN interests or activities. |
| Matteo Miotto |
Matteo Miotto has nothing to disclose. |
| Vishaal Rajani, PhD |
Dr. Rajani has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Rajani has stock in Xenon Pharmaceuticals Inc.. |
| Verner A. Lofstrand, PhD |
Mr. Lofstrand has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Mr. Lofstrand has stock in Xenon Pharmaceuticals. Mr. Lofstrand has received intellectual property interests from a discovery or technology relating to health care. |
| Jan Noukens |
The institution of Mr. Noukens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. |
| Kristen Burford |
Dr. Burford has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Burford has stock in Xenon Pharmaceuticals. Dr. Burford has received intellectual property interests from a discovery or technology relating to health care. |
| Sami Asif |
Mr. Asif has nothing to disclose. |
| Nicholas Smith, MBBS, PhD, FRACP |
The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Forge Bio. The institution of Dr. Smith has received research support from Ultragenyx. The institution of Dr. Smith has received research support from Cyclotherapeutics. The institution of Dr. Smith has received research support from BluebirdBio. The institution of Dr. Smith has received research support from Sanfilippo Children's Foundation. The institution of Dr. Smith has received research support from Medical Research Future Fund. The institution of Dr. Smith has received research support from Women's and Children's Hospital Foundation. |
| Andrea D'Angelo |
Andrea D'Angelo has nothing to disclose. |
| Abigail N. Schwaede, MD |
Dr. Schwaede has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Schwaede has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . |
| Fei Wang, PhD |
Fei Wang, PhD has received personal compensation for serving as an employee of Stoke Therapeutics. |
| James W. Wheless, MD, FAAP, FACP, FAAN, FAES, FCNS, FAAN |
Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius. |
| julie douville, PhD |
Dr. douville has nothing to disclose. |
| Lucy Dougherty, MD |
Ms. Dougherty has nothing to disclose. |
| Ahmed E. Kertam, MBBS |
Dr. Kertam has nothing to disclose. |
| Alison Cutts |
Alison Cutts has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Alison Cutts has stock in Xenon Pharmaceuticals. Alison Cutts has received intellectual property interests from a discovery or technology relating to health care. |
| Melissa Wolf, PT |
Mrs. Wolf has received personal compensation for serving as an employee of Ultragenyx Pharmaceutical. Mrs. Wolf has stock in Ultragenyx Pharmaceutical. |
| Zonaira Mushahid, MBBS |
Dr. Mushahid has nothing to disclose. |
| Abdul Rafeh Awan, MBBS |
Dr. Awan has nothing to disclose. |
| Nigel Colenbier, PhD |
Mr. Colenbier has received personal compensation for serving as an employee of clouds of care. |
| Linda Ottoboni |
Linda Ottoboni has nothing to disclose. |
| Jung Yun Kim |
Mr. Kim has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Mr. Kim has stock in Xenon Pharmaceuticals. Mr. Kim has received publishing royalties from a publication relating to health care. |
| Joseph Sullivan, MD |
Dr. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Sullivan has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Sullivan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Various firms. Dr. Sullivan has stock in Harmony. |
| Celine M. Dube, PhD |
Dr. Dube has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Dube has stock in Xenon Pharmaceuticals. |
| Olivia S. Kim Mcmanus, MD |
Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina . Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Kim Mcmanus has received research support from California Institute for Regenerative Medicine. The institution of Dr. Kim Mcmanus has received research support from National Institutes of Health/NCATS. |
| Jordan S. Dubow, MD |
Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio . |
| Giacomo Comi |
Giacomo Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Giacomo Comi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. |
| Flavia H. Menezes, MD |
Dr. Menezes has received personal compensation for serving as an employee of argenx. |
| Muneeb Ahmad Muneer |
Mr. Muneer has nothing to disclose. |
| Kimberly A. Parkerson, MD, PhD |
Dr. Parkerson has received personal compensation for serving as an employee of Stoke Therapeutics. Dr. Parkerson has stock in Stoke Therapeutics. |
| Velislava Zoteva, PhD |
Dr. Zoteva has received personal compensation for serving as an employee of Clouds of Care. |
| Deepa S. Rajan, MD, FAAN |
Dr. Rajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Rajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Rajan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. The institution of Dr. Rajan has received research support from National Scleroderma Foundation. The institution of Dr. Rajan has received research support from Denali Therapeutics. The institution of Dr. Rajan has received research support from Ultragenyx . The institution of Dr. Rajan has received research support from Regenxbio. The institution of Dr. Rajan has received research support from Takeda. The institution of Dr. Rajan has received research support from Prevail Therapeutics. The institution of Dr. Rajan has received research support from Children's Neuroscience Institute. Dr. Rajan has received intellectual property interests from a discovery or technology relating to health care. |
| Elaine C. Wirrell, MD, FAAN |
Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care. |
| Maria Fuller, PhD |
The institution of Prof. Fuller has received research support from Ultragenyx. The institution of Prof. Fuller has received research support from Paradigm. The institution of Prof. Fuller has received research support from Sanofi. |
| Kelly G. Knupp, MD |
The institution of Dr. Knupp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research. |
| Philip Lambert, PhD |
Dr. Lambert has received personal compensation for serving as an employee of Satellos Bioscience. Dr. Lambert has stock in Satellos Bioscience. Dr. Lambert has received intellectual property interests from a discovery or technology relating to health care. |
| Maegan Soriano, BSc |
Ms. Soriano has received personal compensation for serving as an employee of Xenon Pharmaceuticals . Ms. Soriano has stock in Xenon Pharmaceuticals . |
| Israa Abdeen, MBBS |
Dr. Abdeen has nothing to disclose. |
| Long H. Tu, MD, PhD |
Dr. Tu has received publishing royalties from a publication relating to health care. |
| Heather Lau, MD |
Dr. Lau has received personal compensation for serving as an employee of Ultragenyx. Dr. Lau has stock in Ultragenyx. |
| Emiel Vereycken |
Mr. Vereycken has nothing to disclose. |
| Kendall P. Robbins, BS |
Ms. Robbins has nothing to disclose. |
| Arjun Mahadevan, MSc |
Mr. Mahadevan has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Mr. Mahadevan has stock in Xenon Pharmaceuticals Inc. |
| Ashan S. Fareed, MBBS |
Mr. Fareed has nothing to disclose. |
| Mohammad Burhanuddin, MBBS |
Dr. Burhanuddin has nothing to disclose. |
| Colin M. Roberts, MD |
Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. |
| Barry S. Ticho, MD, PhD |
Dr. Ticho has received personal compensation for serving as an employee of Stoke Therapeutics. |
| Mohammed Sabri Hassanin, MD |
Dr. Hassanin has nothing to disclose. |
| Anna Bogatyreva, MD, PhD |
Dr. Anna has received personal compensation for serving as an employee of argenx BV. |
| Sithara Ramdas, MD, MBBS |
Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pfizer. Dr. Ramdas has received personal compensation in the range of $0-$499 for serving as a Consultant for Italfarmaco. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Ramdas has received research support from Myaware . The institution of Dr. Ramdas has received research support from Norman Collison Foundation. . |
| Federica Rizzo, PhD |
Dr. Rizzo has nothing to disclose. |
| Delia Gagliardi, MD, PhD |
Dr. Gagliardi has nothing to disclose. |
| Salma Allam, MD |
Dr. Allam has nothing to disclose. |
| Steven Petrou, FAHMS |
Dr. Petrou has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Petrou has stock in Praxis Precision Medicines. The institution of Dr. Petrou has received research support from Praxis Precision Medicines. Dr. Petrou has received intellectual property interests from a discovery or technology relating to health care. |
| María Luz Couce, MD, PhD |
Prof. Couce has nothing to disclose. |
| Janelle Celso |
Mrs. Celso has nothing to disclose. |
| J. Helen Cross |
Dr. Cross has nothing to disclose. |
| Pieter van Mierlo, PhD |
Prof. van Mierlo has received personal compensation for serving as an employee of Clouds of Care. Prof. van Mierlo has stock in Clouds of Care. |
| Steven Wesolowski, PhD |
Dr. Wesolowski has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Wesolowski has stock in Xenon Pharmaceuticals. Dr. Wesolowski has received intellectual property interests from a discovery or technology relating to health care. |
| SAI VENKATA MANOJ KOTHARU, MBBS |
Dr. KOTHARU has nothing to disclose. |
| John M. Schreiber, MD |
Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. The institution of Dr. Schreiber has received research support from Dravet Syndrome Foundation. |
| Affan Tasleem, MBBS |
Dr. Tasleem has nothing to disclose. |
| Kaushik Patra, PhD |
Dr. Patra has received personal compensation for serving as an employee of Ultragenyx. Dr. Patra has stock in Ultragenyx. |
| Mohamed A. Mostafa II, MBBS |
Dr. Mostafa has nothing to disclose. |
| Stan Crooke |
No disclosure on file
|
| James Empfield, PhD |
Dr. Empfield has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Empfield has stock in Xenon Pharmaceuticals. |
| Elizabeth M. Berry-Kravis, MD, PhD |
The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Zevra. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren. |
| Ahmed R. Harb |
Mr. Harb has nothing to disclose. |
| Rania naqrashi, MBBS |
Miss naqrashi has nothing to disclose. |
| Courtney Wells |
Ms. Wells has received personal compensation for serving as an employee of Satellos Bioscience, Inc.. Ms. Wells has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for HSG. Ms. Wells has stock in Satellos Bioscience, Inc.. Ms. Wells has stock in Tourmaline. |
| Temitayo Oyegbile-Chidi, MD, PhD, FAAN |
Dr. Oyegbile-Chidi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Spectrum/The Transmitter. The institution of Dr. Oyegbile-Chidi has received research support from NIH. |
| Zainab A. Memon, MBBS |
Dr. Memon has nothing to disclose. |
| Matthew Waldbrook |
Mr. Waldbrook has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Mr. Waldbrook has stock in Xenon Pharmaceuticals. |
| Frank Bennett, PhD |
No disclosure on file
|
| J.P Johnson Jr, PhD |
Dr. Johnson Jr has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Johnson Jr has stock in Xenon Pharmaceuticals. Dr. Johnson Jr has received intellectual property interests from a discovery or technology relating to health care. |
| Tonke van Bragt, MSc |
The institution of Mrs. van Bragt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Mrs. van Bragt has stock in argenx. |
| Liana Protopsaltis, MS, CGC |
Mrs. Protopsaltis has nothing to disclose. |
| Archana Desurkar, MD, MBBS, MRCPCH |
Dr. Desurkar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biocodex. Dr. Desurkar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for STOKE therapeutics. Dr. Desurkar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. |
| Erik Niks, MD, PhD |
Dr. Niks has nothing to disclose. |
| Caroline Neuray |
The institution of Caroline Neuray has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clouds of Care. The institution of Caroline Neuray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Saniona. |
| Gert Vanhollebeke, PhD |
Dr. Vanhollebeke has received personal compensation for serving as an employee of Clouds of Care. |
| Anthony L. Fine, MD |
The institution of Dr. Fine has received research support from Neurocrine Biosciences. The institution of Dr. Fine has received research support from American Board of Psychiatry and Neurology. |
| Dabbara V. Ramana |
Mr. Ramana has nothing to disclose. |